Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2344-2025Class II

OtoLase Starter Kit; UPN: AC-2003748. Indicated for a variety of surgical uses including ablation...

Lumenis Ltd / initiated 2025-07-22 / Open, Classified / root cause: manufacturing process

LUMENIS, LTD. began a recall of OtoLase Starter Kit; UPN: AC-2003748. Indicated for a variety of surgical uses including ablation, coagulation, incision, excision, and vaporization of soft... on . FDA classified it as Class II and gives the reason as "The potential for unsterilized product within finished product labeled as sterile". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2344-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Lumenis Ltd
Product
OtoLase Starter Kit; UPN: AC-2003748. Indicated for a variety of surgical uses including ablation, coagulation, incision, excision, and vaporization of soft tissue.
Product code
GEX Powered Laser Surgical Instrument
Reason for recall
The potential for unsterilized product within finished product labeled as sterile.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On July 22, 2025, URGENT MEDICAL DEVICE REMOVAL - IMMEDIATE ACTION REQUIRED letters were sent to customers. Instructions: " Immediately discontinue use and segregate the affected products to prevent accidental use and follow provided removal instructions on the attachment. " Post this information in a visible location near where the affected products are stored to ensure this information is readily accessible to all handlers and users of the device. Share this notice with any healthcare professional within your organization and with any organization where the affected products may have been transferred. " If you are a distributor, this notification must be forwarded to your customers to ensure notification of this product removal is carried out to the end-user level. " If you are a facility that has sent products to another hospital or a facility within your network, ensure this notification is forwarded to them. Any adverse events or quality concerns associated with use of these devices should be reported to Boston Scientific via email at [email protected] or FDA s MedWatch Adverse Event Reporting program [www.fda.gov/MedWatch/report.htm or 1.800.FDA.1088 (332.1088)]. We appreciate your understanding as we take action to address this issue. At Boston Scientific, patient safety and customer satisfaction are our priority. We are committed to continuing to offer products that meet the quality standards that you expect from Boston Scientific. Contact your local Boston Scientific representative with any questions.
Quantity in commerce
13 units
Distribution
Domestic: PA, WI; International: Germany, India;
Product codes and lots
UPN: AC-2003748; UDI-DI: 07290109142807; Batch Numbers: 32644549 and 32769567; Expiration Date: 22Aug2025;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2344-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2344-2025Class IIOngoingVoluntary: Firm initiated